Haihe Biopharma is a company that develops anti-tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company provides products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions.